Metabolic & Endocrine
Pediatric NAFLD
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Pediatric NAFLD is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
4
clinical trials
Terminated2 · 50%
Completed1 · 25%
Recruiting1 · 25%
Clinical Trials
Trial Activity
Anti-LPS Antibody Treatment for Pediatric NAFLD
Completed·—·Phase 2·NCT03042767·40 enrolled
Losartan for the Treatment of Pediatric NAFLD
Terminated·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 2·NCT03467217·83 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)